MACY CLEVIDENCE: Open Payments
NPI 1447738265 · HENDERSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 19 payments from 8 companies in 2025. Trend: 2023 $539 · 2024 $455 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $154 |
| PFIZER INC. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Amgen Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, UBRELVY, QULIPTA, CAPLYTA, EVENITY, ELIQUIS, NURTEC ODT, SHINGRIX.
Industry payments across KY — which companies pay providers there.
